NCT04965753 2025-03-04FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss TumorsFoghorn Therapeutics Inc.Phase 1 Terminated55 enrolled
NCT00089245 2023-12-26Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal CancerY-mAbs TherapeuticsPhase 1 Terminated177 enrolled